Journal profile · ONCOLOGY
Oncology Reviews
ISSN 1970-5557 · PAGEPress Publications · Italy
Oncology Reviews: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 4 (journal website); fully open access; APC charged, amount not published; median 87 days to acceptance (103 articles, last 24 months); 50 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Oncology Reviews is published by PAGEPress Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer Treatment and Pharmacology, Head and Neck Cancer Studies and Cancer Genomics and Diagnostics, together about 20.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Oncology Reviews is a multidisciplinary journal that focuses on publishing premier reviews on preclinical and clinical aspects of oncology. Oncology Reviews welcomes research contributions in the various domains of oncology, which bridge the gap between basic research and clinical practice. Topics include, but are not limited to: preclinical research in oncology clinical advancements in cancer treatment innovations in cancer diagnostics cancer prevention strategies multidisciplinary approaches to cancer care The journal welcomes submissions that support and advance the Sustainable Development Goal (SDG) 3: Good Health and Well-being. Oncology Reviews contributes to this goal by focusing on research and advancements in oncology, which are crucial for understanding, preventing, and treating various types of cancer. By providing access to up-to-date information, the journal supports the global effort to improve health outcomes and reduce the burden of cancer on individuals, families, and societies. Manuscripts relating to topics outside the scope of oncology or not in line with the journal's mission are not suitable for publication in Oncology Reviews. Frontiers’ journals require that manuscripts primarily comprising computational studies of public data, must include appropriate validation. Please refer to the Frontiers Standards for research methodology policy, for more information. Manuscripts not adhering to these standards will not be considered. Oncology Reviews is committed to advancing developments in the field of oncology by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public alike, to enable the scientific breakthroughs of the future.
From the journal's Aims & Scope
Research area (LetPub): ONCOLOGY
Editor-in-chief David ChiaPublisher website
Editorial board by country: 2 in mainland China (about 11%); most named United States 4, Italy 4, Mainland China 2, Brazil 2, Israel 2 (18 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer Treatment and PharmacologyMedicine8.7%
- Head and Neck Cancer StudiesMedicine5.9%
- Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology5.9%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology5.3%
- Renal cell carcinoma treatmentMedicine4.9%
- Lung Cancer Treatments and MutationsMedicine4.6%
- Hepatocellular Carcinoma Treatment and PrognosisMedicine4.5%
- Cervical Cancer and HPV ResearchMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCEmbasePublisher website
Other: EBSCO, ProQuest, Dimensions, CNKI, CLOCKSS, Crossref
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 4Publisher website ·
- CiteScore 2026-06
- 5LetPub ·
- CiteScore (publisher)
- 5Publisher website ·
- SJR 2026-06
- 1.1LetPub ·
- SNIP 2026-06
- 1.45LetPub ·
- h-index
- 42OpenAlex ·
- i10-index
- 171OpenAlex ·
- 2-year mean citedness
- 4.72OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 48LetPub ·
Articles by year OpenAlex count · 847 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 64 | 64 | 38 |
| 2025 | 50 | 50 | 356 |
| 2024 | 34 | 34 | 305 |
| 2023 | 12 | 12 | 187 |
| 2022 | 9 | 9 | 316 |
| 2021 | 17 | 17 | 185 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
87 daysMedian, submission to acceptance · P25–P75 60 days – 131 days
- Acceptance to online
- median 22 days (103 articles)
- Submission to online
- median 109 days
- Sample
- 103 articles with submission and acceptance dates (124 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 9 weeksLetPub ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 1,950 | Yes | CC BY | |
| OpenAlex | CHF 1,950 | — | — | |
| LetPub | USD 1,900 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- 5–8
- Reference style
- Harvard
- Templates
- LaTeX and Word
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review
- AI use Use of AI to create written or visual content
Authors should not list a generative AI technology as a co-author or author of any submitted manuscript. Generative AI technologies cannot be held accountable for all aspects of a manuscript and consequently do not meet the criteria required for authorship. If the author of a submitted manuscript has used written or visual content produced by or edited using a generative AI technology, this use mu…
Source ↗Publisher website ·- Authorship
Authors must select the appropriate article type and comply with its description and word count limits. Model summary
Frontiers requires authors to select the appropriate article type for their manuscript and to comply with the article type descriptions defined in the journal's 'Article types' page, which can be seen from the 'For authors' menu on every Frontiers journal page. Please pay close attention to the word count limits.
Source ↗Publisher website ·- Conflicts of interest Safeguards against financial conflicts of interest
Only leading researchers acting as Associate Editors, who are not part of Frontiers' staff, can make acceptance decisions based on reviews performed by external experts acting as Community Reviewers or Reviewers. None have a financial incentive to accept articles, i.e. they are not paid for their role as Associate Editor or community Reviewer, and any award scheme is not linked to acceptances of m…
Source ↗Publisher website ·- Publication ethics
Ethics approval statement required in Materials and methods for animal or human subject research. Model summary
For experiments reporting results on animal or human subject research, an ethics approval statement should be included in this section (for further information, see the 'Bioethics' section of our policies and publication ethics.)
Source ↗Publisher website ·- License & copyright Open access and copyright
Figures, tables, and images published under CC-BY; permission required for copyrighted third-party material. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Open access Open access and copyright
Open access under Creative Commons CC-BY license (version 4.0) for all articles from July 2012 onwards; authors retain copyright. Model summary
All Frontiers' articles from July 2012 onwards are published with open access under the Creative Commons CC-BY license (the current version is CC-BY, version 4.0). This means that the author(s) retains copyright, but the content is free to download, distribute, and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article. Upon submission, the author(s)…
Source ↗Publisher website ·- Peer review Peer review
Peer review process description. Model summary
Our rigorous, transparent peer review process combines expert review and constructive dialogue to strengthen your manuscript.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- PAGEPress Publications
- Country or region
- Italy
- Language
- English
- ISSN
- 1970-5557
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Oncology Reviews
What CAS zone is Oncology Reviews in?
In the 2025 upgraded edition of the CAS Journal Ranking, Oncology Reviews is in Zone 4 of Medicine, and in Zone 4 of the minor category Oncology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Oncology Reviews?
The journal's website gives an impact factor of 4; this is the journal's own figure, as LetPub lists none for it; CiteScore 5, h-index 42.
How long does peer review take at Oncology Reviews?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 87 days (interquartile range 60–131 days); authors report an average review time of about 9 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Oncology Reviews?
According to the journal's author guidelines: Keywords: 5–8; Reference style: Harvard; Templates: LaTeX and Word. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Oncology Reviews based?
Of the 18 board members whose country the journal's board page names, 2 (about 11%) are in mainland China; the countries named most often are United States (4), Italy (4) and Mainland China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Oncology Reviews?
According to LetPub and DOAJ records, Oncology Reviews is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science, PMC and Embase; that list has not been checked against each database.
Is Oncology Reviews open access, and what is the APC?
Oncology Reviews is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .